Homepage
RECENT DEVELOPMENTS
RISDIPLAM APPROVED BY EMA

RISDIPLAM APPROVED BY EMA

31.03.2021
Number of Reads : 4033
Share :

A drug called Evrysdi, developed by Roche, offering home use, was approved by the EMA (European Medicines Agency) for the use of SMA patients of all types who are 2 months and older.
https://www.roche.com/media/releases/med-cor-2021-03-30.htm

info@sma.org.tr
0 222 335 57 62
0 546 966 79 05
Batıkent Mahallesi Geven Sokak No: 5/B Tepebaşı / Eskişehir
Terms of Use Privacy and Security KVKK Cookie Preferences